Skip to main content
. 2019 Jan 11;25(4):422–430. doi: 10.1016/j.cmi.2018.12.022

Fig. 2.

Fig. 2

Distribution of viruses identified with high-throughput sequencing and/or subsequent confirmatory assays in the cerebrospinal fluid and brain samples of 41 patients with a potential viral cause of central nervous system infection, according to immune status and clinical manifestations. The number of patients in whom each virus has been identified is mentioned in brackets. Enc., encephalitis; MeEnc., meningoencephalitis; Me., meningitis; CyCV-VN, cyclovirus Viet-Nam; HSV, herpes simplex virus; MeV, measles virus; HuCSFDV1, human CSF-associated densovirus 1; CV-A9, coxsackie virus A9; TosV, Toscana virus; VZV, varicella zoster virus; HAstV, human astrovirus; TBEV, tick-borne encephalitis virus; LCMV, lymphocytic choriomeningitis virus; EBV, Epstein–Barr virus; SLEV, Saint Louis encephalitis virus; CoV, coronavirus; WNV, West Nile virus; undet., undetermined.